Diversity & dementia: how is research bridging the health gap?

External Event - 21st Sep 2022

Why is it important to consider diversity in science? Two thirds of people living with dementia are women, and yet historically women have been underrepresented in research. People who have Down syndrome have an extremely high chance of developing dementia in their lifetime, but they are typically excluded from clinical trials.

Health inequalities are unfair, systematic differences in health between different groups of people. These differences affect people living with dementia in a multitude of ways, and the reasons behind them are complex - as detailed in our new report, 'Diversity and dementia: how is research reducing health disparities?'. But there are steps we can take to mitigate these inequalities, and scientific research has a key part to play. So what are our scientists doing to try and address these issues in their own research?

Join us as we tackle these questions and more in a live, interactive webinar on World Alzheimer's Day (21 September at 18:00 BST). We’ll hear from researchers who are shining a light on the underrepresented groups affected by dementia, advocating for the use of female mice in animal research, and leading the way on expanded and more accessible clinical trials.

The webinar will feature short talks from Dr Frances Wiseman (UK DRI at UCL), Prof Tara Spires-Jones (UK DRI at Edinburgh) and a third speaker to be confirmed. The talks will be followed by a live 20-minute Q&A where questions from the audience, submitted during the event, will be answered by the researchers. The webinar will be chaired by Dr Adrian Ivinson (UK DRI Co-Director).

To register for this webinar, please follow this link.